NV
Nuvectis Pharma, Inc.
NVCT · NASDAQ
$23.99 +4.49% (+$1.03)
1M +25.73%
Market Cap $636.6M
P/E Ratio -
Div. Yield -
ROE 169.47%
Bulios Fair Price
$20.3
15.4% downside
Trenutna cena
$23.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NVCT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 70.10x
EV/EBITDA N/A
P/S N/A
Growth
75 /100
Growing Book val. growth 9.00%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 169.47%
ROA 124.45%
Asset turnover 0.00x
Debt
95 /100
Low Current ratio 1.68x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
56 /100
Moderate EPS volatility 20.75%
Profitable years 0
Beta -0.26x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NVCT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ron Bentsur
Employees
16
Headquarters
Fort Lee
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report